Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Globe Newswire•29/10/2026•06:50 ET
0
Key Highlights
- ➤Eton will report third-quarter 2026 financial results November 5, 2026
- ➤Management conference call and webcast scheduled for 4:30 p.m. ET
- ➤Eton currently has twelve rare disease products
- ➤Five additional product candidates are in late-stage development
DEER PARK, Ill., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2026 financial results on Thursday, November 5, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET.
In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.
Get started
Create a free account to read the full story.